Grown Rogue to report Q3 2026 results, conference call set for Nov. 12

Grown Rogue will report Q3 2026 results after market close on Nov. 12, 2026. A conference call and webcast are scheduled for the same day at 5:00 p.m. ET, with a Q&A session and replay available until Nov. 19, 2026. CEO Obie Strickler and management will discuss the results and provide a corporate update.

Original reporting
Published Oct 20, 2026, 2:23 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 20, 2026, 2:26 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Grown Rogue to report Q3 2026 results, conference call set for Nov. 12 — source image
Decision brief

The 30-second read

$GRUSFNeutralLow
01

Why it matters

The filing provides the first public notice of the earnings release date, offering a scheduling cue for traders but no substantive financial data.

02

Market read

A routine earnings‑release announcement; relevance is limited to short‑term positioning ahead of the results.

03

What to watch

Potential hidden factors such as recent operational developments or market sentiment toward the sector could influence the reaction.

Relevance 6/10Novelty 5/10Timing: after‑market close Nov 12, 2026

Background

The article is an AI‑generated summary of an SEC 8‑K filing announcing the timing of Grown Rogue's Q3 2026 earnings release and conference call.

Company-level read

Ticker impact

$GRUSFNeutralHigh confidence
Context

Grown Rogue International Inc. filed an 8‑K announcing it will release its Q3 2026 results after market close on Nov. 12, 2026.

Expected impact

potential pressure or volatility as the market prices in the pending earnings numbers

Evidence & confidence

Earnings announcements are standard catalysts; no guidance or numbers are provided yet, so impact is limited to typical pre‑release positioning.

Market effects

None disclosed; the filing is a routine earnings announcement for the company.

Limited to investors tracking Grown Rogue; no broader regional effect mentioned.

Minimal; the news pertains only to the individual issuer.

Counterpoint

Without guidance or surprise elements, the earnings release may be a wash, and any price move could be short‑term noise.

Key entities

  • Grown Rogue International Inc.

    Issuer of the 8‑K filing announcing its Q3 2026 earnings release.

Related articles

$GRUSFLow

Grown Rogue Reports Third Quarter 2026 Results

Grown Rogue International Inc. (GRUSF) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Grown Rogue Reports Third Quarter 2026 Results Steady Execution Across Existing and New Markets; 2026 and 2027 Guidance and Growth Targets Maintained MEDFORD, Ore., Nov. 12, 2026 /CNW/ - Grown Rogue International Inc. ("Grown Rogue," "we," "us," "our," or the "Compan

$GRUSFMed

Grown Rogue Reports Second Quarter 2026 Results

Grown Rogue International Inc. (GRUSF) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Grown Rogue Reports Second Quarter 2026 Results Results and KPIs Highlight Continued Execution Against Growth Plans; 2026 and 2027 Guidance Increased MEDFORD, Ore., Aug. 4, 2026 /CNW/ - Grown Rogue International Inc. ("Grown Rogue," "we," "us," "our," or the "Company

$NMAXMed

Why Newsmax Stock Popped on Friday

Newsmax (NMAX) shares rose 31% after reporting Q3 revenue of $69M, up 52.5% YoY, and net income of $15.2M. The company cited strong audience engagement and growth in high-margin revenue streams. CEO Christopher Ruddy expects continued growth ahead of the presidential election.

$LUNRMed

What Is Driving Intuitive Machines Stock?

Intuitive Machines (LUNR) shares rose 7.0% on Nov 12, 2026, after reporting Q3 revenue of $269M, beating estimates. The company's loss of $0.10 per share met expectations, while gross margin improved to 26%. Free cash flow turned positive at $33M, a company record. Management raised full-year revenue guidance to $920M-$950M. The stock's performance contrasted with broader industry declines.

$RMIXMedAI 8/10

Suncrete (RMIX) Q3 2026 Earnings Call Transcript

Suncrete (RMIX) reported Q3 2026 revenue of $141M, up 45% QoQ and 163% YoY. Adjusted EBITDA rose 66% QoQ to $22.4M. The company lowered its full-year outlook due to residential construction weakness but remains confident in long-term demand. Acquisition integration is progressing, with North Texas showing margin improvement. Suncrete expects $200M-$250M revenue from 2026 acquisitions in 2027. The company has $206.5M in total liquidity.

$CLLSMed

Cellectis SA (CLLS) (Q3 2026) Earnings Call Highlights: Strategic Shift to Gene

Cellectis SA (CLLS) discussed its strategic shift to gene editing during its Q3 2026 earnings call. Management highlighted the selection of APOC3 over ANGPTL3 for triglyceride reduction, with plans to start Phase 1 dosing by end-2027. The company reported $149M in cash as of September 30, 2026, with a runway into H2 2028. Revenue decreased to $19.9M from $67.4M YoY, while R&D expenses increased to $108.8M from $69.1M, driven by the AstraZeneca collaboration.